Comparison Overview

MACLEODS PHARMACEUTICALS LTD.

VS

Fresenius Kabi

MACLEODS PHARMACEUTICALS LTD.

304, Atlanta Arcade Marol Church Road, Mumbai, 400059, IN
Last Update: 2026-01-19

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 11,821
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Fresenius Kabi

Else-Kröner-Straße 1, Bad Homburg, Hessen, DE, 61352
Last Update: 2026-01-20

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 23,880
Subsidiaries: 41
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/macleods-pharmaceuticals-ltd..jpeg
MACLEODS PHARMACEUTICALS LTD.
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/freseniuskabi.jpeg
Fresenius Kabi
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
MACLEODS PHARMACEUTICALS LTD.
100%
Compliance Rate
0/4 Standards Verified
Fresenius Kabi
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Fresenius Kabi in 2026.

Incident History — MACLEODS PHARMACEUTICALS LTD. (X = Date, Y = Severity)

MACLEODS PHARMACEUTICALS LTD. cyber incidents detection timeline including parent company and subsidiaries

Incident History — Fresenius Kabi (X = Date, Y = Severity)

Fresenius Kabi cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/macleods-pharmaceuticals-ltd..jpeg
MACLEODS PHARMACEUTICALS LTD.
Incidents

No Incident

https://images.rankiteo.com/companyimages/freseniuskabi.jpeg
Fresenius Kabi
Incidents

Date Detected: 05/2020
Type:Ransomware
Attack Vector: Computer virus outbreak
Blog: Blog

FAQ

Fresenius Kabi company demonstrates a stronger AI Cybersecurity Score compared to MACLEODS PHARMACEUTICALS LTD. company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Fresenius Kabi company has historically faced a number of disclosed cyber incidents, whereas MACLEODS PHARMACEUTICALS LTD. company has not reported any.

In the current year, Fresenius Kabi company and MACLEODS PHARMACEUTICALS LTD. company have not reported any cyber incidents.

Fresenius Kabi company has confirmed experiencing a ransomware attack, while MACLEODS PHARMACEUTICALS LTD. company has not reported such incidents publicly.

Neither Fresenius Kabi company nor MACLEODS PHARMACEUTICALS LTD. company has reported experiencing a data breach publicly.

Neither Fresenius Kabi company nor MACLEODS PHARMACEUTICALS LTD. company has reported experiencing targeted cyberattacks publicly.

Neither MACLEODS PHARMACEUTICALS LTD. company nor Fresenius Kabi company has reported experiencing or disclosing vulnerabilities publicly.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds any compliance certifications.

Neither company holds any compliance certifications.

Fresenius Kabi company has more subsidiaries worldwide compared to MACLEODS PHARMACEUTICALS LTD. company.

Fresenius Kabi company employs more people globally than MACLEODS PHARMACEUTICALS LTD. company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds SOC 2 Type 1 certification.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds SOC 2 Type 2 certification.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds ISO 27001 certification.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds PCI DSS certification.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds HIPAA certification.

Neither MACLEODS PHARMACEUTICALS LTD. nor Fresenius Kabi holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
Description

A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.

Description

A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.

Description

A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.

Risk Information
cvss3
Base: 6.0
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
cvss4
Base: 6.0
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.